These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33961025)

  • 41. Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib.
    Moghadam-Kia S; Charlton D; Aggarwal R; Oddis CV
    Rheumatology (Oxford); 2019 Jun; 58(6):1011-1015. PubMed ID: 30608616
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.
    Martillotti J; Moote D; Zemel L
    Pediatr Radiol; 2014 Jan; 44(1):115-8. PubMed ID: 23839717
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recovery of nail dystrophy potential new therapeutic indication of tofacitinib.
    Jaller JA; Jaller JJ; Jaller AM; Jaller-Char JJ; Ferreira SB; Ferreira R; Scheinberg M
    Clin Rheumatol; 2017 Apr; 36(4):971-973. PubMed ID: 28210825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Initial Experience With Tofacitinib in Clinical Practice: Treatment Patterns and Costs of Tofacitinib Administered as Monotherapy or in Combination With Conventional Synthetic DMARDs in 2 US Health Care Claims Databases.
    Harnett J; Curtis JR; Gerber R; Gruben D; Koenig A
    Clin Ther; 2016 Jun; 38(6):1451-1463. PubMed ID: 27112534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of tofacitinib for slowly progressive interstitial lung disease in a patient with anti-MDA5 antibody-positive dermatomyositis.
    Takatani A; Koga T; Fujita Y; Fukui S; Endo Y; Shimizu T; Kawakami A
    Clin Immunol; 2020 Jun; 215():108451. PubMed ID: 32360518
    [No Abstract]   [Full Text] [Related]  

  • 46. [Retrospective analysis of anti-TIF1gamma, anti-NXP2 and anti-SAE1/2 antibodies carriers at Bordeaux university hospital from November 2014 to February 2017].
    Victor J; Zanardo L; Héron-Mermin D; Poursac N; Solé G; Bordes C; Duffau P
    Rev Med Interne; 2019 Feb; 40(2):70-81. PubMed ID: 30527961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dermatomyositis: new antibody, new classification].
    Bolko L; Gitiaux C; Allenbach Y
    Med Sci (Paris); 2019 Nov; 35 Hors série n° 2():18-23. PubMed ID: 31859626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subcutaneous immunoglobulin for the treatment of calcinosis associated with juvenile dermatomyositis.
    Rodríguez-Lozano AL; Mata-Aguilera X; Rivas-Larrauri F; Bustamante-Ogando JC; Gutierrez-Hernandez A; Bojalil-Cabildo A; Scheffler-Mendoza S; Yamazaki-Nakashimada M
    Int J Rheum Dis; 2024 Jun; 27(6):e15239. PubMed ID: 38923294
    [No Abstract]   [Full Text] [Related]  

  • 49. Tofacitinib or adalimumab versus placebo: patient-reported outcomes from a phase 3 study of active rheumatoid arthritis.
    Strand V; van Vollenhoven RF; Lee EB; Fleischmann R; Zwillich SH; Gruben D; Koncz T; Wilkinson B; Wallenstein G
    Rheumatology (Oxford); 2016 Jun; 55(6):1031-41. PubMed ID: 26929445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral Tofacitinib Treatment of Erosive Pustular Dermatosis of the Scalp.
    Leung N; Eldik H; Ramirez MR; Sodha P
    JAMA Dermatol; 2019 Jun; 155(6):752-754. PubMed ID: 30969310
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of refractory anti-NXP2 and anti-TIF1γ dermatomyositis with tofacitinib.
    Navarro-Navarro I; Jiménez-Gallo D; Rodríguez-Mateos ME; Rodríguez-Hernández C; Linares-Barrios M
    J Dtsch Dermatol Ges; 2021 Mar; 19(3):443-447. PubMed ID: 32909360
    [No Abstract]   [Full Text] [Related]  

  • 52. Successful treatment of calcinosis cutis in juvenile dermatomyositis with pamidronate.
    Palaniappan P; Lionel AP; Kumar S
    J Clin Rheumatol; 2014 Dec; 20(8):454-5. PubMed ID: 25417690
    [No Abstract]   [Full Text] [Related]  

  • 53. Regression of cutis calcinosis with diltiazem in adult dermatomyositis.
    Abdallah-Lotf M; Grasland A; Vinceneux P; Sigal-Grinberg M
    Eur J Dermatol; 2005; 15(2):102-4. PubMed ID: 15757822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib.
    Winthrop KL; Wouters A; Choy EH; Chen C; Biswas P; Wang L; Soma K; Needle E; Valdez H; Rigby WF
    Ann Rheum Dis; 2020 May; 79(5):669-671. PubMed ID: 32161057
    [No Abstract]   [Full Text] [Related]  

  • 55. Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients.
    Paik JJ; Casciola-Rosen L; Shin JY; Albayda J; Tiniakou E; Leung DG; Gutierrez-Alamillo L; Perin J; Florea L; Antonescu C; Leung SG; Purwin G; Koenig A; Christopher-Stine L
    Arthritis Rheumatol; 2021 May; 73(5):858-865. PubMed ID: 33258553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
    Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
    Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients.
    Serdaroğlu S; Engin B; Çelik U; Erkan E; Aşkın Ö; Oba Ç; Kutlubay Z
    Dermatol Ther; 2019 May; 32(3):e12844. PubMed ID: 30693634
    [No Abstract]   [Full Text] [Related]  

  • 58. Successful treatment of dermatomyositis and associated calcinosis with adalimumab.
    Xie F; Williams P; Batchelor R; Downs A; Haigh R
    Clin Exp Dermatol; 2020 Oct; 45(7):945-949. PubMed ID: 33448458
    [No Abstract]   [Full Text] [Related]  

  • 59. Tofacitinib versus methotrexate in rheumatoid arthritis.
    Yuan K; Chen J; Xu A
    N Engl J Med; 2014 Sep; 371(12):1163-4. PubMed ID: 25229928
    [No Abstract]   [Full Text] [Related]  

  • 60. Tofacitinib versus methotrexate in rheumatoid arthritis.
    Sexton D
    N Engl J Med; 2014 Sep; 371(12):1163. PubMed ID: 25229927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.